Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 65 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
• FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung CarcinomaCompletedNCT00086333Phase 2
• Non-small Cell Lung Cancer Study US75 (Z-PACT)CompletedNCT00086268Phase 3
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedNCT00085826Phase 3
• Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerCompletedNCT00085813Phase 2
• S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00085501Phase 2
• Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00085280Not applicable
• Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00084981Phase 1
• Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerCompletedNCT00081315Phase 2
• Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00081302Phase 2
• Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyCompletedNCT00081107Phase 2
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00080340Phase 3
• Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00079287Phase 3
• CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerCompletedNCT00079235Phase 2
• Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CarcinomaCompletedNCT00078455Phase 2
• Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung CancerCompletedNCT00078390Phase 1/2
• A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung CancerCompletedNCT00078260Phase 3
• TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT00077883Phase 1/2
• 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00077415Phase 2
• A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung CancerCompletedNCT00077350Phase 2
• Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung LesionsCompletedNCT00077324
• Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00077311Phase 2
• ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung CancerCompletedNCT00077246Phase 1/2
• Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung CancerStatus unknownNCT00077220Phase 3
• Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)CompletedNCT00076856Phase 2
• Iressa Versus Docetaxel (Taxotere)CompletedNCT00076388Phase 3
• Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00075751Phase 2
• Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00075517Phase 2
• Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00075374Phase 2
• Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00074204Phase 3
• GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid TumorsCompletedNCT00074022Phase 1/2
• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073866Phase 1/2
• Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073723Phase 1/2
• Vaccine Treatment for Advanced Non-Small Cell Lung CancerCompletedNCT00073398Phase 1/2
• Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073385Phase 2
• A Study of ABT-751 in Patients With Non-Small Cell Lung CancerCompletedNCT00073151Phase 2
• Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00072631Phase 2
• Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00072618Phase 1/2
• Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072072Phase 1
• Analysis of Brain Metastasis in Patients With Lung CancerCompletedNCT00071344
• ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT00071188Phase 2
• CPG 7909 Injection in Non-Small Cell Lung CancerCompletedNCT00070629Phase 2
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00070486Phase 2
• A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerCompletedNCT00069875Phase 2
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
• Study Evaluating EKB-569 in Advanced Non-Small Cell Lung CancerCompletedNCT00067548Phase 2
• Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00066885Phase 1/2
• Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerCompletedNCT00066768Phase 1
• Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsTerminatedNCT00064636Phase 1
• 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00064064Phase 2
• Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerCompletedNCT00064012Phase 2
• Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckCompletedNCT00063895Phase 1/2
• Phase II Study in Patients With Recurrent Non-Small-Cell Lung CancerCompletedNCT00063388Phase 2
• Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based TherapyCompletedNCT00063219Phase 2
• Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung CancerStatus unknownNCT00062907Phase 1
• High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00062335Phase 1
• Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00062270Phase 1/2
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00062179Phase 2
• Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00062101Phase 2
• Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung CancerCompletedNCT00062062Phase 2
• Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00061854Phase 2
• Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00061646Phase 2
• Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.CompletedNCT00061464Phase 2
• Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical TrialCompletedNCT00061451Phase 2
• This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.CompletedNCT00059722Phase 2
• Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung CancerCompletedNCT00059605Phase 1
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00058006Phase 2
• Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2
• ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic CancerCompletedNCT00056537Phase 1
• Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinStatus unknownNCT00055965Phase 3
• Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00055887Phase 3
• Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00055757Phase 2
• An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung CancerCompletedNCT00054899Phase 1
• Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)CompletedNCT00054795Phase 3
• Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
• Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054210Phase 3
• Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
• Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerTerminatedNCT00054184Phase 3
• Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00052338Phase 1
• Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00051974Phase 2
• Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaCompletedNCT00051571Phase 2
• ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.CompletedNCT00051493Phase 2
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00050973Phase 3
• Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung CarcinomaCompletedNCT00050674Phase 2
• Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)TerminatedNCT00050336Phase 3
• Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung CancerCompletedNCT00049998Phase 3
• Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung CancerCompletedNCT00049790Phase 2
• Iressa/Docetaxel in Non-Small-Cell Lung CancerWithdrawnNCT00048087Phase 2
• This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.CompletedNCT00047840Phase 2
• Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung CancerCompletedNCT00047801Phase 1/2
• Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer PatientsCompletedNCT00044538Phase 2
• PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)CompletedNCT00043368Phase 2
• Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung CancerTerminatedNCT00042835Phase 1
• A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.CompletedNCT00042679Phase 2
• A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042315Phase 3
• A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042302Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00041314Phase 2
• EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00041028Phase 2
• Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)CompletedNCT00040885Phase 3
• Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00040794Phase 2

← Carcinoma, Non-Small-Cell Lung overview